Bio Monthly (Feb 2025): Bio V1 Launch, $CURES Discovery + Instant Liquidity, BioAgents, Coinbase Futures & More

Highlights:

• Bio V1 development is rapidly progressing, targeting Mainnet deployments on both Solana and Base in the coming weeks.
• The V1 protocol will consist of various components aimed at making early-stage biotech more permissionless and autonomous, including a launchpad, liquidity engine and BioAgents (AI-powered scientific agents integrated with BioDAOs).
• Curetopia, whose auction is ongoing on Bio's V0 launchpad, gives a glimpse into the autonomous nature of Bio V1. The CURES token, if sufficiently funded, will go live on Solana with a BIO/CURES liquidity pool within hours of the auction closing on March 11 at 6pm UTC.

🌐 Dive deeper into the Biosphere 🌐

💻 Dev Updates

• The phased roll-out of Bio V1 was recently discussed in an X Spaces.
• Bio V1 will enable DeSci fair launches (via bonding curves and auctions), automated liquidity, milestone-based incentives (bio/acc rewards), and natively integrated BioAgents.
• The V1 roll-out will start in the coming weeks on both Solana and Base.
• Users will be able to lock or stake BIO tokens to perform core functions on the network (like BioDAO curation or running BioAgents), with protocol fees recycled back into the ecosystem (via liquidity or token burns) to fuel growth.
• To catch up on community discussions, see the proposed V1 Launchpad Overview, Curation & Funding mechanisms. We'll soon share more info and user guides on Bio V1.
• Bio announced BioAgents to accelerate scientific breakthroughs by automating tasks like hypothesis generation and experiment design across BioDAOs. Read the 2025 vision and join our upcoming global BioAgents Hackathon.

💡New BioDAOs

• Curetopia, the first BioDAO on Solana, launched their community auction for $CURES and have raised 1.4k+ SOL so far to fund decentralized trials and drug repurposing in the $1T+ rare disease market. Curetopia announced they've already uncovered clinical discoveries in the lab which they plan to patent onchain, receiving attention from the Solana Foundation. The CURES Auction closes on March 11 -- and if sufficiently funded, a BIO/CURES pool will be deployed within hours of the auction closing. Get $CURES.
• Nootropics DAO launched their commercial arm, Chemiax, with over 30 products available. They're also launching Noot Social, a new app featuring community-driven nootropic formulation, personal N=1 experiments, and a cognitive testing platform.
• Long COVID Labs are launching case studies to treat Long COVID by targeting biomarkers, while collaborating with VitaDAO to identify biomarkers of DNA damage, inflammation, and cellular senescence. They also created their first proposal on their governance process & another on Liquidity.
• SpineDAO are designing tokenomics for a multilabelized healthcare data-sharing system to create practical utility for medical advancements in spine care.
• Quantum Biology DAO expanded to Solana and announced a new hire at their new LA lab, Dr. Michael Montague. They also participated in ETHDenver, presented at the Gordon Research Conference, and passed a 2025 Budget proposal.
• ReflexDAO was announced as a new BioDAO leveraging wearables to plug into DeSci.

🌐 Network Updates

• VitaDAO-backed project CyclarityTx advanced to clinical trials, launching the Heart Harmony Study. VitaDAO also gave updates on VitaLabs-funded projects + a progress update from VitaRNA, and shared early lab data from VitaFast revealing promising molecules, leading to a new proposal to refine and test them, secure IP, and define their lead compound. Additionally, they shared a new proposal for an open-source Virtual Cell AI model by AbuGoot Lab and Prime Intellect to accelerate longevity research.
• PsyDAO launched their first drug token on Solana, $DMXE, a dissociative substance structurally related to methoxetamine and ketamine. They also voted on proposals for psychedelics research and are recruiting expert reviewers to evaluate them - Apply here.
• Molecule pilot-launched Proof of Invention (PoI), a seamless, cost-effective way to establish immutable proof of an invention's origin on a public ledger. They also published a review on DAO token delegation, addressing centralization risks and proposing solutions like quadratic voting, AI-driven tools, and multi-tier governance to improve governance.
• CryoDAO's Gaia project has successfully vitrified, rewarmed, and transplanted 7 whole ovaries from 7 sheep, aiming to produce baby lambs, marking a world-first achievement, facilitated by DeSci.
• Pump Science launched their first set of new compounds $ART & $EGS with airdrops for $RIF and $URO holders. They also published an article on using crypto trading to fund longevity research and tying tokens to supplement sales.
• ValleyDAO is developing an AI-powered feature for their Phlo tool, using a dataset from over 6,000 biotech papers to enhance research efficiency. They were also mentioned in SynBioBeta, discussing how DeSci platforms are accelerating synthetic biology by enabling researchers to fund, conduct, and publish their work while retaining ownership and addressing systemic inequities in TradSci.
• AthenaDAO hosted a Q&A session with lead scientist Mario D. Cordero to discuss their $FACC IPT. The DAO also announced a call for submissions to fund Japan-based Reproductive Longevity projects up to $150k.
• Cerebrum DAO is gathering feedback on their xponetiq app's beta version to enhance brain fitness and introduced the app at the Accelerate BrainHealth conference. They will reveal the full version soon - sign up for the beta.

🧪 Bio Community Updates

• BIO was listed as the first DeSci token on Kraken & Coinbase Futures, marking a significant step towards integrating U.S. scientists and patients into Web3.
• Bio went on a mini-Asia tour hosting DeSci Hong Kong at Consensus 2025 as well as DeSci Tokyo in partnership with Merito Network.
• Bio cofounder Paul Kohlhaas joined The Block to discuss DeSci and what's next for Bio.
• CoinGecko covered Bio and the early stages of DeSci, including Bio’s funding, liquidity, and AI mechanisms, launching soon on Mainnet.
• William Fang joined Bio to lead capital strategy and BD, emphasizing APAC's role in the future of DeSci. William previously worked at Sora Ventures & Goldman Sachs.
• The new DeSci Pilled Podcast was announced with guest Ethan Perlstein from Curetopia featured in the first episode.
• 2077 Research wrote an in-depth article on Bio and the broader DeSci landscape.
• Applications closed for DeSci Edu, our 8-week bootcamp training the next generation of decentralized science innovators.
• Bio participated in ETHDenver 2025, where our Science Lead James Sinka and AI Lead Sean Brennan spoke at a number of side-events.
• We participated in a DeSci panel at the Penn Blockchain Conference 2025 with Quantum Biology DAO, CerebrumDAO, HairDAO, and other DeSci projects.
• Got an idea for a BioDAO? Applications are open on a rolling basis for new BioDAOs to join the Bio ecosystem. Apply here.

Keep up with everything Bio in our Telegram, Discord & Governance forum

‍